759 related articles for article (PubMed ID: 21856723)
21. Autophagy regulates amyotrophic lateral sclerosis-linked fused in sarcoma-positive stress granules in neurons.
Ryu HH; Jun MH; Min KJ; Jang DJ; Lee YS; Kim HK; Lee JA
Neurobiol Aging; 2014 Dec; 35(12):2822-2831. PubMed ID: 25216585
[TBL] [Abstract][Full Text] [Related]
22. ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import.
Dormann D; Rodde R; Edbauer D; Bentmann E; Fischer I; Hruscha A; Than ME; Mackenzie IR; Capell A; Schmid B; Neumann M; Haass C
EMBO J; 2010 Aug; 29(16):2841-57. PubMed ID: 20606625
[TBL] [Abstract][Full Text] [Related]
23. The presence of heterogeneous nuclear ribonucleoproteins in frontotemporal lobar degeneration with FUS-positive inclusions.
Gami-Patel P; Bandopadhyay R; Brelstaff J; Revesz T; Lashley T
Neurobiol Aging; 2016 Oct; 46():192-203. PubMed ID: 27500866
[TBL] [Abstract][Full Text] [Related]
24. Aggregation of FET Proteins as a Pathological Change in Amyotrophic Lateral Sclerosis.
Furukawa Y; Tokuda E
Adv Exp Med Biol; 2017; 925():1-12. PubMed ID: 27311318
[TBL] [Abstract][Full Text] [Related]
25. Altered mRNP granule dynamics in FTLD pathogenesis.
Bowden HA; Dormann D
J Neurochem; 2016 Aug; 138 Suppl 1():112-33. PubMed ID: 26938019
[TBL] [Abstract][Full Text] [Related]
26. TDP-43 and FUS/TLS: cellular functions and implications for neurodegeneration.
Fiesel FC; Kahle PJ
FEBS J; 2011 Oct; 278(19):3550-68. PubMed ID: 21777389
[TBL] [Abstract][Full Text] [Related]
27. Interaction of amyotrophic lateral sclerosis/frontotemporal lobar degeneration-associated fused-in-sarcoma with proteins involved in metabolic and protein degradation pathways.
Wang T; Jiang X; Chen G; Xu J
Neurobiol Aging; 2015 Jan; 36(1):527-35. PubMed ID: 25192599
[TBL] [Abstract][Full Text] [Related]
28. Divergent FUS phosphorylation in primate and mouse cells following double-strand DNA damage.
Johnson MA; Deng Q; Taylor G; McEachin ZT; Chan AWS; Root J; Bassell GJ; Kukar T
Neurobiol Dis; 2020 Dec; 146():105085. PubMed ID: 32950644
[TBL] [Abstract][Full Text] [Related]
29. Arginine methylation next to the PY-NLS modulates Transportin binding and nuclear import of FUS.
Dormann D; Madl T; Valori CF; Bentmann E; Tahirovic S; Abou-Ajram C; Kremmer E; Ansorge O; Mackenzie IR; Neumann M; Haass C
EMBO J; 2012 Nov; 31(22):4258-75. PubMed ID: 22968170
[TBL] [Abstract][Full Text] [Related]
30. FUS/TLS-immunoreactive neuronal and glial cell inclusions increase with disease duration in familial amyotrophic lateral sclerosis with an R521C FUS/TLS mutation.
Suzuki N; Kato S; Kato M; Warita H; Mizuno H; Kato M; Shimakura N; Akiyama H; Kobayashi Z; Konno H; Aoki M
J Neuropathol Exp Neurol; 2012 Sep; 71(9):779-88. PubMed ID: 22878663
[TBL] [Abstract][Full Text] [Related]
31. Atypical FTLD-FUS associated with ALS-TDP: a case report.
Kobayashi Z; Arai T; Yokota O; Tsuchiya K; Hosokawa M; Oshima K; Niizato K; Akiyama H; Mizusawa H
Neuropathology; 2013 Feb; 33(1):83-6. PubMed ID: 22640227
[TBL] [Abstract][Full Text] [Related]
32. Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid.
Bigio EH; Wu JY; Deng HX; Bit-Ivan EN; Mao Q; Ganti R; Peterson M; Siddique N; Geula C; Siddique T; Mesulam M
Acta Neuropathol; 2013 Mar; 125(3):463-5. PubMed ID: 23378033
[No Abstract] [Full Text] [Related]
33. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.
Swarup V; Phaneuf D; Bareil C; Robertson J; Rouleau GA; Kriz J; Julien JP
Brain; 2011 Sep; 134(Pt 9):2610-26. PubMed ID: 21752789
[TBL] [Abstract][Full Text] [Related]
34. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration.
Lagier-Tourenne C; Polymenidou M; Cleveland DW
Hum Mol Genet; 2010 Apr; 19(R1):R46-64. PubMed ID: 20400460
[TBL] [Abstract][Full Text] [Related]
35. Characterization and expression analysis in the developing embryonic brain of the porcine FET family: FUS, EWS, and TAF15.
Blechingberg J; Holm IE; Nielsen AL
Gene; 2012 Feb; 493(1):27-35. PubMed ID: 22143032
[TBL] [Abstract][Full Text] [Related]
36. Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS/TLS.
Ito D; Seki M; Tsunoda Y; Uchiyama H; Suzuki N
Ann Neurol; 2011 Jan; 69(1):152-62. PubMed ID: 21280085
[TBL] [Abstract][Full Text] [Related]
37. FUS pathology in basophilic inclusion body disease.
Munoz DG; Neumann M; Kusaka H; Yokota O; Ishihara K; Terada S; Kuroda S; Mackenzie IR
Acta Neuropathol; 2009 Nov; 118(5):617-27. PubMed ID: 19830439
[TBL] [Abstract][Full Text] [Related]
38. Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutation.
Mackenzie IR; Ansorge O; Strong M; Bilbao J; Zinman L; Ang LC; Baker M; Stewart H; Eisen A; Rademakers R; Neumann M
Acta Neuropathol; 2011 Jul; 122(1):87-98. PubMed ID: 21604077
[TBL] [Abstract][Full Text] [Related]
39. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis.
Deng HX; Zhai H; Bigio EH; Yan J; Fecto F; Ajroud K; Mishra M; Ajroud-Driss S; Heller S; Sufit R; Siddique N; Mugnaini E; Siddique T
Ann Neurol; 2010 Jun; 67(6):739-48. PubMed ID: 20517935
[TBL] [Abstract][Full Text] [Related]
40. Stepwise acquirement of hallmark neuropathology in FUS-ALS iPSC models depends on mutation type and neuronal aging.
Japtok J; Lojewski X; Naumann M; Klingenstein M; Reinhardt P; Sterneckert J; Putz S; Demestre M; Boeckers TM; Ludolph AC; Liebau S; Storch A; Hermann A
Neurobiol Dis; 2015 Oct; 82():420-429. PubMed ID: 26253605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
